DANIEL LYNCH Insider Trading $BIND DNIB UNWIND, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for DANIEL LYNCH.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of DANIEL LYNCH. DANIEL LYNCH is Acting Chief Executive Officer in IMCLONE SYSTEMS INC ($IMCLE) and Chief Executive Officer in IMCLONE SYSTEMS INC ($IMCLE) and in bluebird bio, Inc. ($BLUE) and Director in bluebird bio, Inc. ($BLUE) and Director in BIND Therapeutics, Inc ($BIND) and Director in Eleven Biotherapeutics, Inc. ($EBIO) and Director in Blueprint Medicines Corp ($BPMC) and Director in Translate Bio, Inc. ($TBIO) and Director in Surface Oncology, Inc. ($SURF) and Director in SpringWorks Therapeutics, Inc. ($SWTX).

DANIEL LYNCH in DNIB UNWIND, INC.

Trading Symbol: BIND
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL LYNCH: Director
Holdings: 20,000 shares
Latest Transaction: Aug 30 2016

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of DANIEL LYNCH in DNIB UNWIND, INC.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, BLUE, BPMC, BIND, IMCLE, SESN, SWTX, SURF, TBIO

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Aug 30 2016	BIND	DNIB UNWIND, INC.	LYNCH DANIEL	Director	Option Exercise	M	0.44	20,000	8,800	0
Aug 30 2016	BIND	DNIB UNWIND, INC.	LYNCH DANIEL	Director	Buy	M	0.44	20,000	8,800	20,000	0 to 20 K
Jun 22 2016	BIND	BIND Therapeutics, ...	LYNCH DANIEL	Director	Option Exercise	A	0.44	20,000	8,800	20,000
Jun 10 2015	BIND	BIND Therapeutics, ...	LYNCH DANIEL	Director	Option Exercise	A	5.87	20,000	117,400	20,000

Page: 1